03/05/2019 Transcatheter Heart Valves Greece 2019 | N. Kleiman | Is paravalvular regurgitation after TAVR still an important consideration in 2019?

64 VIEWS EXPANDCOLLAPSE Αρχείο

Share

13,601 total
707 live
64 video
3,531 photo
Views:

3/5Αίθουσα Banquet Hall, MAICC -
14:00-15:45 TAVI Session III – TAVR dilemmas and complications
Πρόεδροι: D. Iliopoulos,G. Hahalis,V. Pyrgakis,S. Tzeis
14:00-14:15 Incidence, predictors and consequences of new LBBB and new PPM after TAVR
L. Papavasileiou
14:15-14:30 Is paravalvular regurgitation after TAVR still an important consideration in 2019?
N. Kleiman
14:30-14:45 A Selective versus Routine Minimalist Strategy. Is every patient eligible?
S. Kapadia
14:45-15:00 Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to consider CABG, timing of PCI and TAVR, and completeness of revascularization)
M. Οto
15:00-15:15 To crack or not to crack? The role for fracturing bioprosthetic valves during ViV procedures
M. Kasel
15:15-15:30 Live-in-a-box TAVR
15:30-15:45 Discussion
Σχολιαστές: I. Chlorogiannis,K. Dimitriadis,A. Zacharoulis


 
Sort by Date | Views

Το 8o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών θα μεταδοθεί ζωντανά στο Livemedia
3 - 4 Μαίου 2019. Το Συνέδριο διοργανώνεται από το Διαγνωστικό Θεραπευτήριο Κέντρο Αθηνών Υγεία και θα πραγματοποιηθεί στο Μέγαρο Μουσικής Αθηνών.

Για περισσότερες πληροφορίες πατήστε εδώ.

G. Pattakos | Latest TAVR Randomized Trials... 110
M. Vavuranakis | High-Quality TAVR: Does... 91
S. Prapas | The selection of SAVR devices... 87
P. Dedeilas | Rapid Deployment Surgical... 79
WELCOME NOTES 85
A. Chalapas | CT Imaging of Bicuspid Aortic... 92
N. Van Mieghem | TAVR will be the treatment... 126
D. Angouras | Most Bicuspid aortic valves... 87
S. Kodali | Strokes After TAVR and SAVR:... 64
R. Mehran | What’s Holding Back Cerebral... 73
M. Οto | TAVR in the patient with significant... 65
A. Halapas | Live in a Box | TAVR Session... 87
L. Papavasileiou | Incidence, predictors... 98
N. Kleiman | Is paravalvular regurgitation... 64
S. Kapadia | A Selective versus Routine... 63
M. Οto | Management of Coronary Disease... 62
M. Chirssoheris | Live in a Box | TAVI Session... 57
A. Katsaros | Impact of valvular heart disease... 66
A. Patrianakos | Patient-prosthesis mismatch... 66
E. Anagnostou | Moderate aortic stenosis... 208
G. Pattakos | Minimally invasive surgery... 63
S. Kodali | In hospital mortality after... 57
G. Giamouzis - G. Karatasakis | JOINT SESSON... 69
S. Kapadia | TAVR for All? New insights... 58
J. Kisslo | Defining Secondary Mitral Regurgitation:... 67
S. Kar | Mitraclip for Functional Mitral... 61
D. Klettas | Exercise-stress echocardiography... 219
K. Spargias | Mitraclip vs. PASCAL. Similarities... 88
K. Papadopoulos | Lessons from the MITRA-FR... 187
S. Kar | Percutaneous mitral repair after... 60
N. Kleiman | Who are the best candidates... 64
F. Maisano | Lessons from an International... 70
M. Chrissoheris | Echocardiographic evaluation... 73
A. Pitsis | Mitral Valve-in-valve and valve-in-ring... 49
J. Velianou | Results of valve-in-MAC (mitral... 61
S. Kar | Currently enrolling TMVR and TTVR... 58
F. Maisano | You can’t beat safety and simplicity:... 59
N. Baikoussis - K. Bellos - E. Petropoulou... 66
K. Papadopoulos | Live in a box Mitraclip... 64
V. Voudris | A growing conundrum: Coronary... 65
N. Van Mieghem | Mechanisms of coronary... 61
N. Bouboulis | Hybrid beating heart bypass... 60
A. Manginas | Guidelines and classification... 53
R. Mehran | TAVR plus/minus AFib and/or... 61
G. Dangas | The Spectrum of Leaflet Thrombosis... 64
Discussion | TAVI Session IV – Avoiding Pitfalls 56
G. Pattakos |Live in a Box | TAVI Session... 68
M. Kasel | To crack or not to crack? The... 59
K. Spargias | Supra-annular TAVR devices.... 60
J. Velianou | To split or not to split?... 53
M. Kasel | The rapid emergence of transcaval... 53
P. Dardas | TAVR in the decompensated patient... 47
K. Dimitriadis | Transcatheter Heart Valves... 46
Discussion | TAVR Session V – Dealing with... 48
A. Οto - Transcatheter Heart Valves Greece... 40
S. Kapadia | Transcatheter Heart Valves Greece... 36
Σ.Παττακός | Transcatheter Heart Valves Greece... 36
K. Spargias | How far should we push the... 51
M. Chrissoheris | Live-in-a-box TAVR | TAVR... 48
A. Holzamer | The ACCURATE Neo TAVR system.... 44
L. Michalis | The PORTICO TAVR system. Program... 45
V. Martzaklis | Medtronic Structural Heart... 46
M. Kasel | What to expect in the near future... 38
L. Michalis | A Deep Dive Into TAVR Cost-Effectiveness... 42
M. Kasel | TAVR device selection in the... 41
J. Kisslo | Three-Dimensional Echocardiography... 48
F. Maisano | Patient selection for transcatheter... 45
M. Chrissoheris | Advanced echocardiography... 55
K. Spargias | Technical tips and tricks... 51
V. Ninios | An often Challenging MitraClip... 46
A. Tzifa | Transcatheter valve-in-valve... 65
A. Pitsis | Minimally invasive surgery for... 44
S. Pattakos | The Structural Heart and Valve... 40
C. Arampatzis | My best and/or my worst... 46
J. Iakovou | My best and/or my worst Structural... 43
G. Katsimagklis | My best and/or my worst... 40
D. Nikas | My best and/or my worst Structural... 50
K. Perreas | My best and/or my worst Structural... 47
K. Spiliotopoulos | My best and/or my worst... 44
K. Triantafyllou | My best and/or my worst... 44
D. Tsikaderis | My best and/or my worst... 43
I. Zarifis | My best and/or my worst Structural... 49
Closing of the conference 44